原发性免疫性血小板减少症的误诊与出血频率:来自麦克马斯特ITP登记研究的经验
该研究建立麦克马斯特ITP登记研究,纳入2010至2016年614例血小板<150×10^9/L的患者,由两名血液科医生依据标准诊断并动态复核。在最终诊断原发性ITP的269例患者中,56.5%(95%CI 50.4-62.5)出现2级出血,2.2%(95%CI 0.8-4.8)发生颅内出血,近1/7患者被误诊。
要点
- 最终诊断原发性ITP患者中56.5%(95%CI 50.4-62.5)出现2级出血。
- 原发性ITP患者中2.2%(95%CI 0.8-4.8)发生颅内出血。
- 近1/7原发性ITP患者被误诊,动态复核可纠正诊断。
核心结论
- 近1/7原发性ITP患者被误诊,2级出血常见。
- 登记数据有助于改善ITP患者的临床和实验室分类。
研究设计与样本
- 研究为麦克马斯特ITP登记研究,纳入2010至2016年加拿大一家三级血液科诊所的614例连续患者,血小板<150×10^9/L。
- 患者完成一组检查并按临床需要管理,由两名血液科医生初始判断血小板减少原因并随时间复核,定期团队会议裁定。
- 出血采用ITP专用工具前瞻性分级(0级无至2级严重),数据通过重复病历审查和源数据验证。
主要发现
- 有>1次访视的患者中位随访1.7年(四分位距0.8-3.4)。
- 注册时初始诊断原发性ITP的295例中,36例(12.2%)在随访期间被重新分类为不同诊断。
- 注册时初始诊断其他血小板减少症的319例中,10例(3.1%)最终被重新分类为原发性ITP。
- 最终诊断原发性ITP的269例中,56.5%(95%CI 50.4-62.5)在1个或以上解剖部位出现2级出血。
- 最终诊断原发性ITP的269例中,2.2%(95%CI 0.8-4.8)发生颅内出血。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonspecific diagnostic criteria and uncertain estimates of severe bleeding events are fundamental gaps in knowledge of primary immune thrombocytopenia (ITP). To address these issues, we created the McMaster ITP Registry. In this report, we describe the methodology of the registry, the process for arriving at the diagnosis, and the frequency of bleeding. Consecutive patients with platelets <150 × 109/L from a tertiary hematology clinic in Canada were eligible. Patients completed a panel of investigations and were managed per clinical need. Two hematologists initially determined the cause of the thrombocytopenia using standard criteria and reevaluated the diagnosis over time, which was adjudicated at regular team meetings. Bleeding was graded from 0 (none) to 2 (severe) prospectively using an ITP-specific tool. Data were validated by duplicate chart review and source verification. Between 2010 and 2016, 614 patients were enrolled. Median follow-up for patients with >1 visit was 1.7 years (interquartile range, 0.8-3.4). At registration, 295 patients were initially diagnosed with primary ITP; of those, 36 (12.2%) were reclassified as having a different diagnosis during follow-up. At registration, 319 patients were initially diagnosed with another thrombocytopenic condition; of those, 10 (3.1%) were ultimately reclassified as having primary ITP. Of 269 patients with a final diagnosis of primary ITP, 56.5% (95% confidence interval [CI], 50.4-62.5] experienced grade 2 bleeding at 1 or more anatomical site, and 2.2% (95% CI, 0.8-4.8) had intracranial hemorrhage. Nearly 1 in 7 patients with primary ITP were misdiagnosed. Grade 2 bleeding was common. Registry data can help improve the clinical and laboratory classification of patients with ITP.
引用
- Arnold DM, Nazy I, Clare R, et al. Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry. Blood Adv. 2017. PMID: 29296891. doi:10.1182/bloodadvances.2017010942
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。